Valproic Acid
Iatrogenic
Sun Yat-sen UniversitySmall moleculeUnknownActive
C
35/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 20/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Iatrogenic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Bisoprolol Fumarate Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Isosorbide Dinitrate Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Rosuvastatin Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Aspirin Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Pioglitazone Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Corpril Ukrainian Medical Stomatological Academy | Phase 4 | BB |
Acalabrutinib Polish Lymphoma Research Group | Phase 2 | B |
Hydrocortisone Mahidol University | Phase 2 | CCC |
Same molecule, other indications
Valproic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →